- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 8.46M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.37M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.11M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.11M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.34M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $45.54K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.85M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $239.42K |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 3.25M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$89.7K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$1.32M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$977.56K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $100.78K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $198.96K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$339.43K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$299.74K |